Better Ways to Treat Hypothyroidism
New Approaches for the treatment of Hypothyroidism
This project looks for the best way to combine two thyroid hormones, LT4 and LT3, to help people with hypothyroidism feel better and reduce heart risks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11158865 on NIH RePORTER |
What this research studies
Many people with hypothyroidism take levothyroxine (LT4), but some still experience heart-related risks and a lower quality of life, possibly because their bodies miss the T3 hormone normally made by the thyroid. While some past studies have explored adding T3 to LT4, the results have been mixed, partly due to concerns about T3's short lifespan in the body and potential heart side effects. This project aims to discover the safest and most effective dose and timing for T3 when combined with LT4. The goal is to establish a clear treatment plan that can be used in larger future studies.
Who could benefit from this research
Good fit: People with hypothyroidism who are currently treated with levothyroxine but still experience symptoms or have cardiovascular risks might be ideal candidates.
Not a fit: Patients whose hypothyroidism is well-managed with current levothyroxine treatment and who do not experience ongoing symptoms or cardiovascular concerns may not see additional benefit from this specific approach.
Why it matters
Potential benefit: If successful, this could lead to a new, more effective, and safer treatment option for people with hypothyroidism, potentially improving their quality of life and reducing cardiovascular risks.
How similar studies have performed: While some previous clinical trials with T3-containing therapies have shown promise, a systematic assessment of optimal dosing and frequency for combination therapy is still needed.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Celi, Francesco S — University of Connecticut Sch of Med/dnt
- Study coordinator: Celi, Francesco S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.